A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Status:
RECRUITING

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension

PHASE3

Addpharma Inc.